Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
University of Colorado, Boulder
mi
from
Boulder, CO
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
University of Colorado, Boulder
mi
from
Boulder, CO
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
The Urology Center of Colorado
mi
from
Denver, CO
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
The Urology Center of Colorado
mi
from
Denver, CO
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Urology Associates of Dover, PA
mi
from
Dover, DE
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
Urology Associates of Dover, PA
mi
from
Dover, DE
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
South Florida Medical Research
mi
from
Miami, FL
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
South Florida Medical Research
mi
from
Miami, FL
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Florida Foundation For Healthcare Research
mi
from
Ocala, FL
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
Florida Foundation For Healthcare Research
mi
from
Ocala, FL
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Palm Beach Urology Associates
mi
from
Wellington, FL
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
Palm Beach Urology Associates
mi
from
Wellington, FL
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Premier Urology Associates, LLC
mi
from
Lawrence, NJ
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
Premier Urology Associates, LLC
mi
from
Lawrence, NJ
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Urology Group of New Mexico
mi
from
Albuquerque, NM
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
Urology Group of New Mexico
mi
from
Albuquerque, NM
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Northeast Urology Research
mi
from
Concord, NC
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
Northeast Urology Research
mi
from
Concord, NC
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Urology San Antonio Research PA
mi
from
San Antonio, TX
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
Urology San Antonio Research PA
mi
from
San Antonio, TX
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Urology of Virginia
mi
from
Norfolk, VA
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
Urology of Virginia
mi
from
Norfolk, VA
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Seattle Urology Research Center
mi
from
Seattle, WA
A Degarelix Trial in Patients With Prostate Cancer
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Status: Archived
Updated: 1/1/1970
Seattle Urology Research Center
mi
from
Seattle, WA
Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2
Acceleration Adoption of Comparative Effectiveness Research Results With Patient Decision Support Intervention and Treatment- Study 2
Status: Archived
Palo Alto Medical Foundation Research Institute
mi
from
Palo Alto, CA
Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2
Acceleration Adoption of Comparative Effectiveness Research Results With Patient Decision Support Intervention and Treatment- Study 2
Status: Archived
Updated: 1/1/1970
Palo Alto Medical Foundation Research Institute
mi
from
Palo Alto, CA
Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2
Acceleration Adoption of Comparative Effectiveness Research Results With Patient Decision Support Intervention and Treatment- Study 2
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2
Acceleration Adoption of Comparative Effectiveness Research Results With Patient Decision Support Intervention and Treatment- Study 2
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated:  12/31/1969
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated: 12/31/1969
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated:  12/31/1969
CCOP - Grand Rapids
mi
from
Grand Rapids, MI
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated: 12/31/1969
CCOP - Grand Rapids
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated:  12/31/1969
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated: 12/31/1969
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated:  12/31/1969
CCOP - Main Line Health
mi
from
Wynnewood, PA
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated: 12/31/1969
CCOP - Main Line Health
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated:  12/31/1969
CCOP - Greenville
mi
from
Greenville, SC
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated: 12/31/1969
CCOP - Greenville
mi
from
Greenville, SC
Click here to add this to my saved trials
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson CCOP Research Base
mi
from
Houston, TX
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson CCOP Research Base
mi
from
Houston, TX
Click here to add this to my saved trials
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated:  12/31/1969
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated: 12/31/1969
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Click here to add this to my saved trials
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated:  12/31/1969
CCOP - Wichita
mi
from
Wichita, KA
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated: 12/31/1969
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated:  12/31/1969
CCOP - Scott and White Hospital
mi
from
Temple, TX
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program
Status: Enrolling
Updated: 12/31/1969
CCOP - Scott and White Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
VELCADE® (Bortezomib) for Injection Therapy for Early Relapsed Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
VELCADE® (Bortezomib) for Injection Therapy for Early Relapsed Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Click here to add this to my saved trials
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
VELCADE® (Bortezomib) for Injection Therapy for Early Relapsed Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Loma Linda University Cancer Institute at Loma Linda University Medical Center
mi
from
Loma Linda, CA
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
VELCADE® (Bortezomib) for Injection Therapy for Early Relapsed Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Loma Linda University Cancer Institute at Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
VELCADE® (Bortezomib) for Injection Therapy for Early Relapsed Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
VELCADE® (Bortezomib) for Injection Therapy for Early Relapsed Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
VELCADE® (Bortezomib) for Injection Therapy for Early Relapsed Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
VELCADE® (Bortezomib) for Injection Therapy for Early Relapsed Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
Docetaxel Plus 6-month Androgen Suppression and Radiation Therapy Versus 6-month Androgen Suppression and Radiation Therapy for Patients With High Risk Localized or Locally Advanced Prostate Cancer: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute and (Sanofi-Aventis Consortium)
mi
from
Boston, MA
Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
Docetaxel Plus 6-month Androgen Suppression and Radiation Therapy Versus 6-month Androgen Suppression and Radiation Therapy for Patients With High Risk Localized or Locally Advanced Prostate Cancer: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute and (Sanofi-Aventis Consortium)
mi
from
Boston, MA
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Birmingham
mi
from
Birmingham, AL
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
Southern Arizona VA Health Care System, Tucson
mi
from
Tucson, AZ
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
Southern Arizona VA Health Care System, Tucson
mi
from
Tucson, AZ
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Long Beach
mi
from
Long Beach, CA
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Long Beach
mi
from
Long Beach, CA
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA San Diego Healthcare System, San Diego
mi
from
San Diego, CA
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA San Diego Healthcare System, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, San Francisco
mi
from
San Francisco, CA
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Greater Los Angeles Healthcare System, West LA
mi
from
West Los Angeles, CA
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Greater Los Angeles Healthcare System, West LA
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Connecticut Health Care System
mi
from
West Haven, CT
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Connecticut Health Care System
mi
from
West Haven, CT
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
North Florida/South Georgia Veterans Health System
mi
from
Gainesville, FL
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
North Florida/South Georgia Veterans Health System
mi
from
Gainesville, FL
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Miami
mi
from
Miami, FL
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
James A. Haley Veterans Hospital, Tampa
mi
from
Tampa, FL
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
James A. Haley Veterans Hospital, Tampa
mi
from
Tampa, FL
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Augusta
mi
from
Augusta, GA
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Augusta
mi
from
Augusta, GA
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
Jesse Brown VAMC (WestSide Division)
mi
from
Chicago, IL
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
Jesse Brown VAMC (WestSide Division)
mi
from
Chicago, IL
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Lexington
mi
from
Lexington, KY
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Lexington
mi
from
Lexington, KY
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
Overton Brooks VA Medical Center, Shreveport
mi
from
Shreveport, LA
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
Overton Brooks VA Medical Center, Shreveport
mi
from
Shreveport, LA
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Ann Arbor Healthcare System
mi
from
Ann Arbor, MI
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Ann Arbor Healthcare System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
John D. Dingell VA Medical Center, Detroit
mi
from
Detroit, MI
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
John D. Dingell VA Medical Center, Detroit
mi
from
Detroit, MI
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Minneapolis
mi
from
Minneapolis, MN
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
G.V. (Sonny) Montgomery VA Medical Center, Jackson
mi
from
Jackson, MS
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
G.V. (Sonny) Montgomery VA Medical Center, Jackson
mi
from
Jackson, MS
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Kansas City MO
mi
from
Kansas City, MO
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Kansas City MO
mi
from
Kansas City, MO
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
New Mexico VA Health Care System, Albuquerque
mi
from
Albuquerque, NM
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
New Mexico VA Health Care System, Albuquerque
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Western New York Healthcare System at Buffalo
mi
from
Buffalo, NY
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Western New York Healthcare System at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials